COPART vs ELAN
COPART (COPART) versus Elanco Animal Health (ELAN) — a side-by-side from cached financials, not a winner call.
COPART (COPART) common stock.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
COPART does not have a complete income-statement cache yet.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
ELAN currently screens at market cap $11.80B.
Not investment advice. Open the COPART and ELAN stock pages for the full models.
Not investment advice.